New research suggests that people taking semaglutide medications like Ozempic for diabetes may have a reduced risk of drug overdose. Prescriptions for semaglutide were associated with lower overdose rates in patients with type 2 diabetes and opioid use disorder. While more research is needed to confirm the link between GLP-1 drugs and overdose prevention, the preliminary findings are promising. These medications have shown potential in treating substance use disorders, including opioid addiction. Although GLP-1 drugs have side effects, they could provide an alternative option for patients struggling with opioid use disorder. Further studies are necessary to explore semaglutide as a possible treatment for combating the opioid epidemic.
Source link
Ozempic linked to lower opioid overdose rate, study shows
